1st Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for METACEL PHARMACEUTICALS, LLC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitor and evaluate the congressional agenda and administration proposals relating to oral solution treatments.

LobbyistCovered position, as disclosed
ALICE HARPER NETTLES —
MICHAEL P STRAZZELLA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Monitor and evaluate the congressional agenda and administration proposals relating to oral solution treatments.

LobbyistCovered position, as disclosed
ALICE HARPER NETTLES —
MICHAEL P STRAZZELLA —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Pharmacy PHA

Monitor and evaluate the congressional agenda and administration proposals relating to oral solution treatments.

LobbyistCovered position, as disclosed
ALICE HARPER NETTLES —
MICHAEL P STRAZZELLA —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.